| CAS ID: | 220620-09-7 |
| Molecular Formula: | C29H39N5O8 |
| Molecular Weight: | 585.7 g/mol |
| Monoisotopic Mass: | 585.2799 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | TIGECYCLINE | TYGACIL | WAY-GAR-936 |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36,38-39,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1 | See All |
| InChI Key: | FPZLLRFZJZRHSY-HJYUBDRYSA-N | |
| Smiles: | CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)N(C)C | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00406237 | Disease | Liver fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | December 4, 2006 | Last Verified | April 4, 2011 |
| Sponsor | Wyeth is now a wholly owned subsidiary of Pfizer | ||
| PubChem: | 54686904 |
| ChEMBL: | CHEMBL376140 |